business development virtual pediatric lecture series

40
Business Development Virtual Pediatric Lecture Series SARS-COVID-19 Impact on the Pediatric Heart July 28, 2021, 12:30 – 1:30 PM (PST)

Upload: others

Post on 04-May-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Business Development Virtual Pediatric Lecture Series

B u s i n e s s D e v e l o p m e n t V i r t u a l

P e d i a t r i c L e c t u r e S e r i e s

S A R S - C O V I D - 1 9I m p a c t o n t h e P e d i a t r i c H e a r t

July 28, 2021, 12:30 – 1:30 PM (PST)

Page 2: Business Development Virtual Pediatric Lecture Series

SARS-COVID-19Impact on the Pediatric

Heart

Sanjay Sinha MD

Assistant Professor Pediatrics

Interventional Pediatric Cardiology

UC Irvine Department of Pediatrics/CHOC CS Cardiology

UCLA Department of Pediatrics

2

Page 3: Business Development Virtual Pediatric Lecture Series

Disclosures -No Relevant Disclosures

Page 4: Business Development Virtual Pediatric Lecture Series

Goals

•Review the impact of COVID 19 in the context of pediatric mortality/morbidity

•Viral affect on the pediatric heart

• To describe MIS-C and present the most up to date data

• To discuss data on vaccine related cardiac side effects

Page 5: Business Development Virtual Pediatric Lecture Series
Page 6: Business Development Virtual Pediatric Lecture Series
Page 7: Business Development Virtual Pediatric Lecture Series
Page 8: Business Development Virtual Pediatric Lecture Series
Page 9: Business Development Virtual Pediatric Lecture Series

Pediatric Global effect

• Infected estimated:

+4 million

• Dead estimated: 10k

• Loss of primary caregiver:

1,134, 000

• Loss of primary or secondary caregiver:

1,562,000

• Orphaned: 1,042,000

• Hillis, S., Unwin, H., Chen, Y., Cluver, L., Sherr, L., Goldman, P., ... & Flaxman, S. (2021). Under the radar: global minimum estimates for COVID-19-associated orphanhood and deaths among caregivers.

Page 10: Business Development Virtual Pediatric Lecture Series

COVID-19 Timeline

Page 11: Business Development Virtual Pediatric Lecture Series

Walker DM, Tolentino VR. COVID-19: The impact on pediatric emergency care. Pediatr Emerg Med Pract. 2020 Jun 5;17(Suppl 6-1):1-27. PMID: 32496723.

Page 12: Business Development Virtual Pediatric Lecture Series

Rai, D., et al. (2021). "Differences in clinical and lab characteristics between adults and children

hospitalized with COVID-19 infection over a 2-month period at a tertiary COVID care center: A cross-

sectional study." Lung India 38(4): 402-404.

• Cardiac Effect mixed• No echocardiographic evidence

of effect• In patients with severe disease,

cardiac effects were related to lung disease, pna

• Athletes recovering from COVID-19 showed some evidence of myocarditis by MRI

Page 13: Business Development Virtual Pediatric Lecture Series

Siripanthong, B., et al. (2020). "Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management." Heart Rhythm 17(9): 1463-1471.

ADULT LITERATURE

Page 14: Business Development Virtual Pediatric Lecture Series
Page 15: Business Development Virtual Pediatric Lecture Series

Meanwhile in Kids……

Page 16: Business Development Virtual Pediatric Lecture Series

Then this on May 6 2020…..

Page 17: Business Development Virtual Pediatric Lecture Series

MIS-CMultisystem Inflammatory Syndrome in Children

• October 29, 2020N Engl J Med 2020; 383:1793-1796DOI: 10.1056/NEJMc2026136

Page 18: Business Development Virtual Pediatric Lecture Series

14 year old on his experience with MISC-C

“You could feel it going through your veins and it was almost like someone injected you with straight-up fire,”

Page 19: Business Development Virtual Pediatric Lecture Series

April 8th 2020

Page 20: Business Development Virtual Pediatric Lecture Series

4.9mm Right Coronary Artery

4/8/2020

Normal Left Main Coronary system

4/26/2020

Page 21: Business Development Virtual Pediatric Lecture Series
Page 22: Business Development Virtual Pediatric Lecture Series

Coronary Artery Dilation and Aneurysm

Page 23: Business Development Virtual Pediatric Lecture Series

Cardiac Impact

•Decreased left ventricular ejection fraction

•Pericarditis, myocarditis

•Coronary artery dilation and aneurysm formation

•Heart block

Page 24: Business Development Virtual Pediatric Lecture Series

• Royal College of Paediatrics and Child Health Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19

Page 25: Business Development Virtual Pediatric Lecture Series

Key Points• Occurs 2-4 weeks after SARS-CoV-2 Infection• Dysregulated Immune response to infection• Most Common Presenting Sx

• GI pain• Fever

CARDIAC EFFECT-Decreased left ventricular ejection fraction-Pericarditis, myocarditis-Coronary artery dilation and aneurysm

formation-Heart block

ANTI-INFLAMMATORY/IMMUN MOD TREATMENTRECOVERY IN 1-2 WEEKSLONG TERM CV EFFECTS ARE UNKNOWN

“KAWASAKI LIKE ILLNESS”

Page 26: Business Development Virtual Pediatric Lecture Series
Page 27: Business Development Virtual Pediatric Lecture Series
Page 28: Business Development Virtual Pediatric Lecture Series
Page 29: Business Development Virtual Pediatric Lecture Series

But then!

Page 30: Business Development Virtual Pediatric Lecture Series

mRNA VACCINE RELATED MYOCARDITISKEY POINTS• 12.6 CASES/MILLION DOSES OF 2ND SHOT• 12-39 YEAR OLDS• ADOLESCENT MALE PREDOMINANT• PRESENTATION

• CHEST PAIN 2-3 DAYS AFTER 2ND

DOSE (86%)• Elevated Cardiac Enzymes (64%)• CRP/ESR elevated, but decreased

with Cardiac Enzymes• ST ELEVATIONS IN MULTIPLE LEADS• Abnormal Echo in 40% • MRI EVIDENCE OF MYOCARDITIS• NO EVIDENCE OF CONCOMMITANT

INFECTION

Page 31: Business Development Virtual Pediatric Lecture Series

mRNA VACCINE RELATED MYOCARDITIS

• Approximately 300 Million doses given through June 11 2021

• 1,226 case reported through VAERs

• 67% after 2nd dose

• 79% Males

• Majority younger than 30y/o (median age 24)

Page 32: Business Development Virtual Pediatric Lecture Series

MECHANISM OF ACTION

• SPIKE PROTEIN MOLECULAR MIMICRY

• Trigger dysregulated immune pathways in some individuals

• Unknown why male predominance

Page 33: Business Development Virtual Pediatric Lecture Series

Case Series

Page 34: Business Development Virtual Pediatric Lecture Series

Vaccine Related

Myocarditis Data

Page 35: Business Development Virtual Pediatric Lecture Series

Risk Benefit- Vaccine Counseling

• Share the Facts

• Be updated on the facts

• NEJM

• CIRCULATION

• CDC

• Recognize politically charged environment

• Realize that we are all fathers/brothers/sisters who are afraid.

Page 36: Business Development Virtual Pediatric Lecture Series

Risk Benefit

Page 37: Business Development Virtual Pediatric Lecture Series

Thank you for your time!

Page 38: Business Development Virtual Pediatric Lecture Series

Additional Bibliography

• Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020 May 23;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1. Epub 2020 May 7. PMID: 32386565; PMCID: PMC7204765.

• Farooqi KM, Chan A, Weller RJ, Mi J, Jiang P, Abrahams E, Ferris A, Krishnan US, Pasumarti N, Suh S, Shah AM, DiLorenzo MP, Zachariah P, Milner JD, Rosenzweig EB, Gorelik M, Anderson BR; Columbia University Interdisciplinary MIS-C Follow-up Program and the CUIMC Pediatric/Adult Congenital Heart Research Collaborative. Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children. Pediatrics. 2021 Jul 15:e2021051155. doi: 10.1542/peds.2021-051155. Epub ahead of print. PMID: 34266903.

• Farooqi, K. M., et al. (2021). "Longitudinal Outcomes for Multisystem Inflammatory Syndrome in Children." Pediatrics: e2021051155.

• Matsubara, D., et al. (2020). "Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States." Journal of the American College of Cardiology 76(17): 1947-1961.

• Kim HW, Jenista ER, Wendell DC, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;Epub ahead of print.

Page 39: Business Development Virtual Pediatric Lecture Series

39

PRACTICE INFORMATION

CHOC Specialists Cardiology and Cardiothoracic Surgery

CHOC Commerce Tower

505 S. Main St., Suite 600, Orange, CA 92868

Scheduling: 888-770-2462, Office and after hours: 714-509-3939

Fax: 855-246-2329

choc.org/heart

CHOC Heart Services

Holmes Tower at CHOC Hospital

1201 W. La Veta Ave., 3rd Floor, Orange, CA 92868

Scheduling: 888-770-2462, Front Desk: 714-509-9200

Additional Locations

Corona, Mission Viejo, Newport Beach, Pomona & Whittier

Physicians available via Telehealth and pingmd®

Specialty Care Physician Concierge Service: 714-509-4013

Page 40: Business Development Virtual Pediatric Lecture Series

THANK YOU